# Tag: XP Research

- [Iron ore rises, but China fundamentals remain fragile, XP says](https://brazilstockguide.com/insights/iron-ore-rises-but-china-fundamentals-remain-fragile-xp-says/) (2026-09-11): Recent gains have been supported by seasonal restocking, while steel demand, production and the property sector remain under pressure.
- [The enduring elite of Brazil’s corporate boards](https://brazilstockguide.com/behind-the-lines/the-enduring-elite-of-brazils-corporate-boards/) (2026-09-10): XP data show that a relatively small group of directors holds a disproportionate share of board seats, raising questions about renewal and independence at Brazil’s listed companies.
- [MSCI Forces Global Funds to Buy Itaú and Aura, Dump Totvs](https://brazilstockguide.com/insights/msci-brazil-rebalancing-itau-aura-totvs/) (2026-05-13): Index reshuffle creates forced demand for Itaú common shares and Aura Minerals, while Totvs faces technical selling as MSCI rewires Brazil exposure.
- [Nubank Upgraded to Buy as XP Sees 54% Upside](https://brazilstockguide.com/insights/nubank-stock-outlook-xp-upgrade-54-upside/) (2026-03-31): Report highlights low valuation after 20% drop, with credit, SMEs and Mexico as key growth drivers into 2026.
- [Ultrapar Builds Rumo Stake, Fueling Speculation of Larger Move](https://brazilstockguide.com/insights/ultrapar-builds-rumo-stake-fueling-speculation-of-larger-move/) (2025-11-27): XP analysts say leverage can support a bigger bet despite short-term valuation pressure.
- [Liquidity to Shape the Success of Oncoclínicas’ ‘Back to Basics’ Strategy](https://brazilstockguide.com/insights/liquidity-to-shape-the-success-of-oncoclinicas-back-to-basics-strategy/) (2025-11-22): XP says a more predictable funding environment will determine whether the oncology group’s reset translates into sustainable deleveraging or remains a temporary relief.